Acinar cell plasticity and development of pancreatic ductal adenocarcinoma

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 5, 2017, Pages 296-304

  Storz, Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR ALPHA; UVOMORULIN;

ACINAR CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL EXPANSION; CELL PLASTICITY; EARLY CANCER DIAGNOSIS; GENE EXPRESSION; GENE MUTATION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; METAPLASIA; METASTASIS; NONHUMAN; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; REVIEW; ANIMAL; DISEASE MODEL; MOUSE; NUCLEAR REPROGRAMMING; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY;

ACINAR CELLS; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELLULAR REPROGRAMMING; DISEASE MODELS, ANIMAL; HUMANS; MICE; PANCREATIC NEOPLASMS;

EID: 85014571316     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2017.12     Document Type: Review

References (119)

1. Stanger, B. Z. & Hebrok, M. Control of cell identity in pancreas development and regeneration. Gastroenterology 144, 1170-1179 (2013).
2. Pinho, A. V. et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut 60, 958-966 (2011).
3. Rooman, I. & Real, F. X. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Gut 61, 449-458 (2012).
4. Liou, G. Y. et al. Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-kappaB and MMPs. J. Cell Biol. 202, 563-577 (2013).
5. Logsdon, C. D. & Ji, B. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin. Gastroenterol. Hepatol. 7, S40-S43 (2009).
6. Liou, G. Y. et al. Mutant KRas-induced mitochondrial oxidative stress in acinar cells upregulates EGFR signaling to drive formation of pancreatic precancerous lesions. Cell Rep. 14, 2325-2336 (2016).
7. Hezel, A. F. et al. Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol. Cell. Biol. 28, 2414-2425 (2008).
8. Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L. & Lee, D. C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61, 1121-1135 (1990).
9. Liou, G. Y. et al. Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat. Commun. 6, 6200 (2015).
10. Means, A. L. et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132, 3767-3776 (2005).
11. Shi, G. et al. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene 32, 1950-1958 (2013).
12. Liu, J. et al. TGF-beta1 promotes acinar to ductal metaplasia of human pancreatic acinar cells. Sci. Rep. 6, 30904 (2016).
13. Houbracken, I. et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology 141, 731-741.e4 (2011).
14. Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737-750 (2012). Using lineage tracing of pancreatic cell populations, the authors show that ductal and centroacinar cells are refractory to transformation by oncogenic KRAS, whereas acinar cells undergo metaplasia to a duct-like state and form precursors for PDAC.
15. Ardito, C. M. et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell 22, 304-317 (2012).
16. Ji, B. et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology 137, 1072-1082.e6 (2009). Part of a series of papers from the Logsdon laboratory showing that acquisition of an oncogenic form of KRAS alone is not sufficient to drive development of PDAC. To progress to PDAC, the activities of wild-type and mutant KRAS need to be further increased.
17. Navas, C. et al. EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell 22, 318-330 (2012).
18. Guerra, C. et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19, 728-739 (2011).
19. Guerra, C. et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291-302 (2007).
20. Liou, G. Y. et al. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov. 5, 52-63 (2015). The authors show that acquisition of an oncogenic KRAS mutation in acinar cells can induce the expression of chemoattractants for inflammatory macrophages, which then contribute to the ADM process.
21. Bardeesy, N. & DePinho, R. A. Pancreatic cancer biology and genetics. Nat. Rev. Cancer 2, 897-909 (2002).
22. Aichler, M. et al. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J. Pathol. 226, 723-734 (2012).
23. Wagner, M., Luhrs, H., Kloppel, G., Adler, G. & Schmid, R. M. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115, 1254-1262 (1998).
24. Rodolosse, A. et al. PTF1alpha/p48 transcription factor couples proliferation and differentiation in the exocrine pancreas [corrected]. Gastroenterology 127, 937-949 (2004).
25. Masui, T. et al. Replacement of Rbpj with Rbpjl in the PTF1 complex controls the final maturation of pancreatic acinar cells. Gastroenterology 139, 270-280 (2010).
26. Campos, M. L. et al. ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. Biochem. J. 451, 395-405 (2013).
27. Benitz, S. et al. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells. Oncotarget 7, 11424-11433 (2016).
28. Krah, N. M. et al. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. eLife 4, e07125 (2015).
29. Pin, C. L., Rukstalis, J. M., Johnson, C. & Konieczny, S. F. The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J. Cell Biol. 155, 519-530 (2001).
30. Direnzo, D. et al. Induced Mist1 expression promotes remodeling of mouse pancreatic acinar cells. Gastroenterology 143, 469-480 (2012).
31. Johnson, C. L. et al. Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1. J. Pathol. 228, 351-365 (2012).
32. Shi, G. et al. Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia. Gastroenterology 136, 1368-1378 (2009).
33. Zhu, L. et al. Inhibition of Mist1 homodimer formation induces pancreatic acinar-to-ductal metaplasia. Mol. Cell. Biol. 24, 2673-2681 (2004).
34. Jia, D., Sun, Y. & Konieczny, S. F. Mist1 regulates pancreatic acinar cell proliferation through p21 CIP1/ WAF1. Gastroenterology 135, 1687-1697 (2008).
35. Grabliauskaite, K. et al. p21(WAF1) (/Cip1) limits senescence and acinar-to-ductal metaplasia formation during pancreatitis. J. Pathol. 235, 502-514 (2015).
36. Martinelli, P. et al. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice. Gut 65, 476-486 (2016).
37. Hermann, P. C. et al. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Gastroenterology 147, 1119-1133 (2014).
38. Kim, S. et al. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential. Pancreas 44, 718-727 (2015).
39. Dey, P., Rachagani, S., Vaz, A. P., Ponnusamy, M. P. & Batra, S. K. PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia. Oncotarget 5, 4480-4491 (2014).
40. von Figura, G., Morris, J. P. IV, Wright, C. V. & Hebrok, M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Krasmediated pancreatic neoplastic initiation. Gut 63, 656-664 (2014).
41. Wang, Y. J. et al. Dicer is required for maintenance of adult pancreatic acinar cell identity and plays a role in Kras-driven pancreatic neoplasia. PLoS ONE 9, e113127 (2014).
42. Flandez, M. et al. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)- driven pancreatic tumourigenesis. Gut 63, 647-655 (2014).
43. Morris, J. P. IV et al. Dicer regulates differentiation and viability during mouse pancreatic cancer initiation. PLoS ONE 9, e95486 (2014).
44. Lu, C. D. et al. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma. Cancer 85, 1250-1260 (1999).
45. Jeannot, P. et al. Loss of p27Kip(1) promotes metaplasia in the pancreas via the regulation of Sox9 expression. Oncotarget 6, 35880-35892 (2015).
46. Kopp, J. L. et al. Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 138, 653-665 (2011).
47. Furuyama, K. et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat. Genet. 43, 34-41 (2011).
48. Prevot, P. P. et al. Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia. Gut 61, 1723-1732 (2012).
49. Shroff, S. et al. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum. Pathol. 45, 456-463 (2014).
50. Grimont, A. et al. SOX9 regulates ERBB signalling in pancreatic cancer development. Gut 64, 1790-1799 (2015).
51. Chen, N. M. et al. NFATc1 links EGFR signaling to induction of Sox9 transcription and acinar-ductal transdifferentiation in the pancreas. Gastroenterology 148, 1024-1034.e9 (2015).
52. Hessmann, E. et al. NFATc4 regulates Sox9 gene expression in acinar cell plasticity and pancreatic cancer initiation. Stem Cells Int. 2016, 5272498 (2016).
53. Park, J. Y. et al. Pdx1 expression in pancreatic precursor lesions and neoplasms. Appl. Immunohistochem. Mol. Morphol. 19, 444-449 (2011).
54. Rose, S. D., Swift, G. H., Peyton, M. J., Hammer, R. E. & MacDonald, R. J. The role of PTF1-P48 in pancreatic acinar gene expression. J. Biol. Chem. 276, 44018-44026 (2001).
55. Gu, G., Dubauskaite, J. & Melton, D. A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447-2457 (2002).
56. Wescott, M. P. et al. Pancreatic ductal morphogenesis and the Pdx1 homeodomain transcription factor. Mol. Biol. Cell 20, 4838-4844 (2009).
57. Marty-Santos, L. & Cleaver, O. Pdx1 regulates pancreas tubulogenesis and E-cadherin expression. Development 143, 101-112 (2016).
58. Oliver-Krasinski, J. M. et al. The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. J. Clin. Invest. 119, 1888-1898 (2009).
59. Hale, M. A. et al. The homeodomain protein PDX1 is required at mid-pancreatic development for the formation of the exocrine pancreas. Dev. Biol. 286, 225-237 (2005).
60. Miyatsuka, T. et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 20, 1435-1440 (2006).
61. Corcoran, R. B. et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res. 71, 5020-5029 (2011).
62. Gruber, R. et al. YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK-STAT3 signaling. Gastroenterology 151, 526-539 (2016).
63. Zhang, W. et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci. Signal. 7, ra42 (2014).
64. De La, O. J. et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl Acad. Sci. USA 105, 18907-18912 (2008).
65. Esni, F. et al. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 131, 4213-4224 (2004).
66. Hald, J. et al. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev. Biol. 260, 426-437 (2003).
67. Avila, J. L., Troutman, S., Durham, A. & Kissil, J. L. Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma. PLoS ONE 7, e52133 (2012).
68. Hosokawa, S. et al. Impact of Sox9 dosage and Hes1-mediated Notch signaling in controlling the plasticity of adult pancreatic duct cells in mice. Sci. Rep. 5, 8518 (2015).
69. Delous, M. et al. Sox9b is a key regulator of pancreaticobiliary ductal system development. PLoS Genet. 8, e1002754 (2012).
70. Grippo, P. J. & Sandgren, E. P. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents. Int. J. Cancer 131, 1243-1248 (2012).
71. Wei, D. et al. KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis. Cancer Cell 29, 324-338 (2016).
72. Hall, P. A. & Lemoine, N. R. Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J. Pathol. 166, 97-103 (1992).
73. Greer, R. L., Staley, B. K., Liou, A. & Hebrok, M. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia. Gastroenterology 145, 1088-1097.e8 (2013).
74. Hendley, A. M. et al. p120 Catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas. Dev. Biol. 399, 41-53 (2015).
75. Criscimanna, A., Coudriet, G. M., Gittes, G. K., Piganelli, J. D. & Esni, F. Activated macrophages create lineage-specific microenvironments for pancreatic acinar- and beta-cell regeneration in mice. Gastroenterology 147, 1106-1118.e11 (2014).
76. Kowalik, A. S. et al. Mice lacking the transcription factor Mist1 exhibit an altered stress response and increased sensitivity to caerulein-induced pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1123-G1132 (2007).
77. Karki, A. et al. Silencing Mist1 gene expression is essential for recovery from acute pancreatitis. PLoS ONE 10, e0145724 (2015).
78. Fendrich, V. et al. Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 135, 621-631 (2008).
79. Kong, B. et al. Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. Gut http://dx.doi.org/10.1136/ gutjnl-2015-310913 (2016).
80. Baer, R. et al. Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110alpha. Genes Dev. 28, 2621-2635 (2014).
81. Wu, C. Y. et al. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Gastroenterology 147, 1405-1416.e7 (2014).
82. Payne, S. N. et al. PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors. Oncogenesis 4, e169 (2015).
83. Collins, M. A., Yan, W., Sebolt-Leopold, J. S. & Pasca di Magliano, M. MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice. Gastroenterology 146, 822-834.e7 (2014).
84. Heid, I. et al. Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology 141, 719-730.e7 (2011).
85. Xu, H. N., Nioka, S., Chance, B. & Li, L. Z. Heterogeneity of mitochondrial redox state in premalignant pancreas in a PTEN null transgenic mouse model. Adv. Exp. Med. Biol. 701, 207-213 (2011).
86. Hill, R. et al. PTEN loss accelerates KrasG12D-induced pancreatic cancer development. Cancer Res. 70, 7114-7124 (2010).
87. Eser, S. et al. Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. Cancer Cell 23, 406-420 (2013).
88. Elghazi, L. et al. Regulation of pancreas plasticity and malignant transformation by Akt signaling. Gastroenterology 136, 1091-1103 (2009).
89. Albury, T. M. et al. Constitutively active Akt1 cooperates with KRasG12D to accelerate in vivo pancreatic tumor onset and progression. Neoplasia 17, 175-182 (2015).
90. Weiss, G. A. et al. Evaluation of phosphatidylinositol- 3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma. J. Gastrointest. Oncol. 4, 20-29 (2013).
91. Sawey, E. T., Johnson, J. A. & Crawford, H. C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc. Natl Acad. Sci. USA 104, 19327-19332 (2007).
92. Maniati, E. et al. Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. J. Clin. Invest. 121, 4685-4699 (2011).
93. Palagani, V. et al. Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. Carcinogenesis 35, 859-866 (2014).
94. Carriere, C., Young, A. L., Gunn, J. R., Longnecker, D. S. & Korc, M. Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage. PLoS ONE 6, e27725 (2011).
95. Shi, C. et al. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol. Cancer Res. 7, 230-236 (2009).
96. Huang, H. et al. Oncogenic K-Ras requires activation for enhanced activity. Oncogene 33, 532-535 (2014).
97. Clark, C. E., Beatty, G. L. & Vonderheide, R. H. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. Cancer Lett. 279, 1-7 (2009).
98. Rosati, A. et al. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Nat. Commun. 6, 8695 (2015).
99. Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168-1178 (2015).
100. Makohon-Moore, A. & Iacobuzio-Donahue, C. A. Pancreatic cancer biology and genetics from an evolutionary perspective. Nat. Rev. Cancer 16, 553-565 (2016).
101. Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361 (2012). The authors show that previously tagged pancreatic epithelial cells invade and enter the blood stream at a stage when malignancy could not be detected by histological means. A majority of the circulating pancreatic epithelial cells express DCLK1 as a marker.
102. Rhim, A. D. et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology 146, 647-651 (2014).
103. Bailey, J. M. et al. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology 146, 245-256 (2014). In this paper, Bailey et al. show that precancerous lesions contain a subpopulation of cells positive for DCLK1. Using lineage tracing they demonstrate the acinar origin of these DCLK-positive cells.
104. Qu, D. et al. Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. PLoS ONE 10, e0118933 (2015).
105. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
106. Delgiorno, K. E. et al. Identification and manipulation of biliary metaplasia in pancreatic tumors. Gastroenterology 146, 233-244.e5 (2014).
107. Westphalen, C. B. et al. Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesis. Cell Stem Cell 18, 441-455 (2016).
108. Basturk, O. et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am. J. Surg. Pathol. 39, 1730-1741 (2015).
109. Newman, K. et al. Pancreatic carcinoma with multilineage (acinar, neuroendocrine, and ductal) differentiation. Int. J. Clin. Exp. Pathol. 2, 602-607 (2009).
110. Esposito, I. et al. Hypothetical progression model of pancreatic cancer with origin in the centroacinaracinar compartment. Pancreas 35, 212-217 (2007).
111. Tanaka, M. et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12, 183-197 (2012).
112. Strobel, O. et al. Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo. Proc. Natl Acad. Sci. USA 104, 4419-4424 (2007).
113. Grippo, P. J., Nowlin, P. S., Demeure, M. J., Longnecker, D. S. & Sandgren, E. P. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res. 63, 2016-2019 (2003).
114. Sanchez-Munoz, A. et al. Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer. BMC Cancer 10, 136 (2010).
115. Tuveson, D. A. et al. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res. 66, 242-247 (2006).
116. Habbe, N. et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc. Natl Acad. Sci. USA 105, 18913-18918 (2008).
117. Cornish, T. C. & Hruban, R. H. Pancreatic intraepithelial neoplasia. Surg. Pathol. Clin. 4, 523-535 (2011).
118. Real, F. X. A catastrophic hypothesis for pancreas cancer progression. Gastroenterology 124, 1958-1964 (2003).
119. Ohlund, D., Elyada, E. & Tuveson, D. Fibroblast heterogeneity in the cancer wound. J. Exp. Med. 211, 1503-1523 (2014).